Samaritan on-time, on budget
"We're on schedule, and we're on budget," Joe Kunkel, project director for the hospital construction, said March 11.
"We are well underway," Samaritan Healthcare Director of Communications Gretchen Youngren said. (We're) about 60% complete and headed toward temporary occupancy toward the end of the year, which is really exciting for our community."
Things weren't always so smooth. Back in 2018, residents of the hospital district approved the money to build a new hospital to replace the building on East Wheeler Road that's served the community since 1955. But like so many other things, the project was derailed by COVID-19, and when the world opened up again after the pandemic, the costs had skyrocketed, and the original money voted for the hospital was no longer enough. It wasn't until April 2023 that the hospital was able to get a bond passed to build the new facility.
Once construction began, however, the project has been straightforward. The outer part of the structure is just about finished, Kunkel said.
"There's just a couple of stair towers around the back that need the cladding on them," Kunkel said.
There's a lot more to building a hospital than just the basic structure, Youngren said.
"They are building it in phases," she said. "If you walked through the building today, you'd say, 'Wow, the ER is basically complete.' But then you go over to the other end ... and there's still things left to be done because of how they designed the building."
The landscaping is due to begin in a few weeks, Kunkel said, and with Moses Lake's water challenges, the focus is on efficiency.
"(In) Moses Lake there's not a whole bunch of green and you don't want to be irrigating 55 acres," Kunkel said. "We're trying to be responsible with low water usage. So, we kind of saved the more dense or lush landscaping for right around the building that you actually get to enjoy as a as a visitor, and the outside parts will be more native grasses (with) low water requirements."
The hospital is the biggest part of Samaritan Healthcare, but it's far from the whole thing, Youngren said, and Samaritan is making changes to the entire patient experience.
"We are investing in training and updates across our campuses, the hospital and our two clinics and our business office," she said. "It's everything from how are we answering phones to directing folks in what they can expect at the new hospital campus, but also how do we create a pathway for them to go back to their routine primary care when they leave the hospital? We're looking at that across our entire organization."
Something that hasn't been decided is what to do with the existing Samaritan Hospital. The building on Wheeler Road has served the community since 1955, but it's time to pass it on to another entity, Youngren said. Which agency that will be is still up in the air; Youngren said Samaritan has been in talks with several potential buyers but it's too early to discuss any specifics. One path Samaritan is exploring includes talking with legislators about a potential behavioral or mental health facility, something she said was frequently cited in a survey of the community Samaritan took last year.
"The one thing we are committed to is this building will not sit empty and this building will not become an eyesore for the community," she said. "Our goal and hope is that we can either transition the building to another agency or sell the building."
Building a hospital is a huge undertaking, Kunkel said, and seeing it come to fruition on schedule is not something to take for granted.
"When you get to do one of these projects, you don't realize the thousands of little things you do every day that end up with somebody being taken care of in a bed," he said. "These projects make you think about all those because you do every one of those little things ... (besides) the construction and equipment, we're coordinating with all the IT folks on all the low-voltage and wireless stuff, and all of the nurse call systems and camera systems and holy smokes, there's a reason that hospitals are expensive to build. They're complex buildings."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
11 minutes ago
- San Francisco Chronicle
The COVID pandemic may have aged your brain. Here's what the science says
The COVID-19 pandemic left an indelible mark on society — and now, new research suggests it may have also prematurely aged our brains by an average of 5.5 months, even among those who never caught the virus. In a study published in Nature Communications on Tuesday, researchers from the University of Nottingham in Britain analyzed brain scans from nearly 1,000 adults taken both before and after the pandemic began. The team investigated whether the global crisis had affected brain health. They used artificial intelligence trained on pre-pandemic data from more than 15,000 healthy participants in the U.K. Biobank to model normal brain aging. When applied to the new scans, the algorithm revealed a clear pattern: People who lived through the pandemic — regardless of infection status — showed signs of accelerated structural brain aging. 'What surprised me most was that even people who hadn't had COVID showed significant increases in brain aging rates,' said lead author Dr. Ali-Reza Mohammadi-Nejad, a researcher at the University of Nottingham, in a paper accompanying the study. 'It really shows how much the experience of the pandemic itself, everything from isolation to uncertainty, may have affected our brain health.' The effects were most pronounced in men, older adults and individuals from socioeconomically disadvantaged backgrounds. While only those who had been infected with COVID-19 showed measurable declines in cognitive performance — such as slower thinking and reduced mental flexibility—structural brain changes were observed across the broader population. 'This study reminds us that brain health is shaped not only by illness, but by our everyday environment,' said Dorothee Auer, senior author of the study. The long-term impact of these changes remains unknown, but the researchers say the findings highlight the need to consider the mental and neurological effects of large-scale social disruption. 'Brain health can be influenced by everyday life activities, and major societal disruptions — like those experienced during the pandemic — can leave a mark even in healthy individuals,' Mohammadi-Nejad said. 'This adds to our understanding of public health by reinforcing the importance of considering mental, cognitive and social well-being alongside traditional physical health indicators during future crisis-response planning.'
Miami Herald
5 hours ago
- Miami Herald
Covid-19 drug company liquidates assets in Chapter 11 bankruptcy
When the Covid-19 public health crisis began in the U.S. with the first confirmed case of the 2019 Novel Coronavirus in Washington state on Jan. 20, 2020, the terrifying pandemic was underway, and the Centers for Disease Control and Prevention would report its first confirmed death from the virus on Feb. 29. By March 3, 2020, CDC reported 60 confirmed cases in 12 states. On March 13, the first Trump administration declared a national emergency, and states started implementing shutdowns on March 15, according to the CDC's timeline of Covid-19 events. Don't miss the move: Subscribe to TheStreet's free daily newsletter Biotechnology firms Pfizer-BioTech and Moderna Therapeutics began developing Covid-19 vaccines in March 2020, and by November 2020, each company's Covid-19 vaccine would be found 95% effective in clinical trials. Related: CVS rival pharmacy chain files for Chapter 11 bankruptcy Another biotech firm, Regeneron, in November received approval of an antibody treatment to significantly reduce virus levels within days. In December 2020, Covid-19 vaccinations began, and by Dec. 24, 1 million people had been vaccinated in the U.S. CDC said that by June 1, 2022, the U.S. reported over 84 million Covid-19 infections and over 1 million deaths. About a year later, Pfizer reported on its website that on May 5, 2023, the World Health Organization declared an end to the Covid-19 public health emergency, while the U.S. Department of Health & Human Services did the same on May 11, 2023. The healthcare industry's response to the Covid-19 pandemic was so effective that beginning on May 1, 2024, hospitals were no longer required to report Covid-19 hospital admissions, hospital capacity, or hospital occupancy data to the U.S. Department of Health & Human Services through the Centers for Disease Control and Prevention's National Healthcare Safety Network, according to the CDC website. The end of the crisis also ended the need for massive amounts of Covid-19 drugs. With the Covid-19 pandemic subsiding, companies that stepped forward to develop vaccines, drugs, and treatments during the crisis are now facing declining demand for their services to develop Covid-19 products. With no dire need for Covid-19 products, some drug companies have been forced to downsize or even shut down operations because of a lack of business opportunities. Essential drug manufacturer Aluchua Government Services Inc., which developed Covid-19 therapy drugs under U.S. government contracts, has filed for Chapter 11 bankruptcy with plans to wind down operations and sell its assets. Related: Giant healthcare company files Chapter 11 bankruptcy seeking sale The Aluchua, Fla.-based pharmaceutical company filed its petition in the U.S Bankruptcy Court for the District of Delaware, listing $50 million in assets and $100 million to $500 million in liabilities. The debtor's largest creditors include United States International Development Finance Corp., owed $246 million; Defense Contract Management Agency, owed $11.95 million; and Sigma-Aldrich Inc. $1.33 million. Aluchua was founded in 1999 to develop new drugs and to increase efficacy of existing ones. In 2013, it was awarded a greenfield contract with the U.S. Department of Defense, and in February 2020, it was awarded a contract to develop an advanced monoclonal antibody therapy against Covid-19 infection. The Covid-19 drug was one of several that the debtor partnered with the U.S. government to develop and produce drugs, vaccines, and treatments. The debtor needed to file for Chapter 11 protection after demand for its services began to decline in late 2023 and certain government contracts were wound down or scaled back, according to Aluchua's Chief Restructuring Officer Janet R. Naifeh of FTI Consulting Inc. Aluchua's efforts to replace its government business with commercial contracts failed, which forced it to scale down production and lay off 125 employees from January through April 2025. It reduced its staff by another 67 employees on June 20 and July 1, which, combined with the earlier layoffs, amounted to termination of 80% of its workforce. The company employed 13 full-time and three temporary workers as of the petition date. The company marketed itself for sale beginning in February 2025, but was unable to complete a transaction and decided its only viable option was to file for Chapter 11 bankruptcy, wind down its business, and sell its assets. Related: Iconic retail chain closing its remaining stores in bankruptcy The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Yahoo
5 hours ago
- Yahoo
Summer Covid cases are rising across the U.S. — Is it time for a vaccine?
As Covid cases begin to rise this summer, many may be wondering: What are my risks, and is it time to get another vaccine? As of July 15, Covid cases were growing or likely growing in 27 states including Texas, Illinois, Kentucky, Virginia and Ohio, according to the Centers for Disease Control and Prevention. Rates of positive Covid tests have also been increasing in recent weeks, the CDC says, specifically in the southern region of the country. N.B.1.8.1 is the current dominant variant in the United States, accounting for 43% of all new Covid cases, according to the CDC. It's an offshoot of the XVD.1.5.1 strain, a descendant of the omicron variant. N.B.1.8.1 was responsible for a surge in hospitalizations in China earlier this year. It's been nicknamed 'razor blade throat,' as there have been anecdotal reports of some people getting painful sore throats, said Dr. William Schaffner, an infectious disease expert at Vanderbilt University Medical Center in Nashville, Tennessee. Schaffner noted, however, that sore throats have been a common symptom of Covid since it first began spreading. 'I doubt the clinical spectrum of Covid has changed substantially,' Schaffner said. Do I need a Covid booster? When will the new vaccines be available? The uptick in cases comes as many Americans have likely gone a year or longer without a Covid shot. In May, the Food and Drug Administration asked drugmakers to update their Covid vaccines to target the LP.8.1 strain, a descendent of JN.1, which began spreading widely in 2023 and is another offshoot of omicron. LP.8.1 currently accounts for 31% of all new cases, per the CDC. The new shots won't be available until the fall, and are expected to be approved only for adults 65 and up and kids and adults with at least one medical condition that puts them at risk of severe illness. Healthy kids and adults who want a shot may have to find an older version or pay out of pocket. A single dose can cost as much as $140. Experts say, however, that population immunity — whether from vaccination, prior infection or both — may shield much of the public for now. 'While we don't have a lot of high level of immunity in the population right now, because it's been so long, we may have enough low level immunity to just make it a little bit harder for that virus to transmit easily from person to person,' said Andy Pekosz, an infectious disease researcher at Johns Hopkins University. Indeed, weekly hospitalization rates have remained low, suggesting that the new variant may not be leading to severe illness. The number of cases are still drastically lower than those this time last year, when the test positivity rate peaked in August at 17.9%. The 2025 season has yet to scrape 5%. Pekosz said it isn't unusual for cases to rise during the summer time, when people are likely to crowd indoors to escape the heat. However, he believes that if there is a summer surge of cases, it will be a small one. 'The variants have been around for a while and haven't caused any major surges up until date,' Pekosz said. 'So again, I'm hopeful that if we see a surge, it'll be a low level surge compared to previous years.' Dr. Ofer Levy, director of the precision vaccines program at Boston Children's Hospital, who has advised the FDA, said people who are at high risk of severe illness still may want to consider getting a Covid shot, if they can find one. High risk groups include: Older adults People with weakened immune systems Pregnant women Those with underlying health conditions, such as asthma and heart disease Getting a shot is especially important, Levy said, for those who haven't had one in over a year and whose immunity has likely waned. 'If you're in a high risk group and you're in a state where cases are rising, you may want to just get the first available appointment and get a shot to protect yourself,' he said. People at high risk can then consider getting an additional Covid shot when the updated vaccines are distributed in the fall, he said. Covid has two waves a year Schaffner, of Vanderbilt, said people in the high risk groups may also want to consider wearing a mask during indoor activities, such as the movies. Healthy adults and children may be able to wait longer before getting another shot, Levy added. 'If you're in a lower risk group, that's where things get fuzzy,' he said. 'I mean if you want a vaccine and your health care provider concurs and you can get it.' Dr. Michael Phillips, an infectious disease doctor at NYU Langone, said that he sees mostly immunocompromised and older adults test positive for the virus. For those who haven't gotten a Covid shot in years, Phillips said he doesn't think they should worry just yet. 'If you're younger, otherwise healthy, I think you're OK,' Phillips said. 'If you have underlying pulmonary disease, you know, if you're an older age group, now that's a time when you should be really talking to a doctor and saying, 'Gosh, should I be getting a booster for Covid?'' He said that the amount of positive Covid tests NYU Langone has seen has decreased 40% since February. Fatima Amaeka, a senior analyst at the Center for Outbreak Response Innovation at Johns Hopkins, said she expects the current wave to peak around September. Schaffner said to expect another wave in the late fall and winter. '[Covid] has two increases each year,' he said. 'Everyone is familiar with the winter increase that goes along with flu and RSV.' This article was originally published on Solve the daily Crossword
